Go to main page
+§ Audited by PwC

Statement of the Board of Directors and the Management

The Board of Directors and the Management have considered and approved the Annual Report for 2006 of Novozymes A/S.

The consolidated financial statements are presented in accordance with the International Financial Reporting Standards (IFRS), as adopted by the EU, and the Parent Company financial statements are presented in accordance with the Danish Financial Statements Act. In addition, the Annual Report has been prepared in accordance with the additional Danish annual report requirements for listed companies.

In our opinion, the accounting policies used are appropriate, the Group’s internal controls relevant to preparation and presentation of an annual report are adequate, and the Annual Report gives a true and fair view of the Group’s and the Parent Company’s assets, liabilities and financial position at December 31, 2006 and of the results of the Group’s and the Parent Company’s operations and consolidated cash flows for the financial year 2006.

The Annual Report is recommended for approval by the Annual Meeting of Shareholders.

Gladsaxe, January 25, 2007

 

Management:

 

Steen Riisgaard
President and CEO

 

Per Falholt

 

Benny D. Loft

 

Peder Holk Nielsen

 

Arne W. Schmidt

 

Board of Directors:



Henrik Gürtler
Chairman
Kurt Anker Nielsen
Vice-Chairman
Paul Petter Aas
 
Arne Juul Hansen 
 
 Jerker Hartwall
  



Søren Henrik Jepsen
Ulla Morin Walther Thygesen Hans Werdelin  

 
Executive Management
Board of Directors
Reporting Updates

"Reporting Updates" is a live reporting universe providing valuable information relevant to Novozymes' reporting several times a year.
Go to "Reporting Updates".  

Others have read